APOE and Alzheimer disease: Data from Framingham Heart Study outline the influence of hypertriglyceridemia (≥287 mg/dL for males and ≥226 mg/dL for females) during midlife (40–60 years of age) on late-onset AD risk in APOE e4 negative participants, after adjustment for systolic blood pressure, and based on genetic markers.